ORCHARD THERAPEUTICS PLC Deferred Revenue (Non-Current)
ORCHARD THERAPEUTICS PLC had Deferred Revenue (Non-Current) of $10.35 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2023-11-13
- 2023-09-30: Deferred Revenue, Noncurrent $10.35M.
- 2023-06-30: Deferred Revenue, Noncurrent $10.82M.
- 2023-03-31: Deferred Revenue, Noncurrent $10.78M.
- 2022-12-31: Deferred Revenue, Noncurrent $10.31M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2023-09-30 | $10.35M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $10.82M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $10.78M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $10.31M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $9.10M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $10.29M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $11.55M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $12.52M 10-K · filed 2023-03-14 |
| 2021-09-30 | $11.50M 10-Q · filed 2021-11-04 |